Aliviane Inc Methadone Treatment Program - El Paso Texas

Aliviane Inc Methadone Treatment Program - El Paso, TX

Aliviane Inc Methadone Treatment Program is treatment facility located at 1626 Medical Center Drive, Suite 100 in the 79902 zip code in El Paso, TX that offers medication-assisted treatment for addiction. Aliviane Inc Methadone Treatment Program provides buprenorphine detox, methadone maintenance and buprenorphine maintenance to young adults and adults. Some of the treatment approaches used by Aliviane Inc Methadone Treatment Program consist of motivational interviewing, cognitive behavioral therapy and relapse prevention. Aliviane Inc Methadone Treatment Program also includes detox programs and offers opioid detox.

Address: 1626 Medical Center Drive, Suite 100, El Paso, TX 79902

1. Types of Care
2. Service Settings
3. Opioid Medications used in Treatment
4. Type of Alcohol Use Disorder Treatment
5. Type Of Treatment
6. Pharmacotherapies
7. Treatment Approaches
8. FacilityOwnership
9. License/Certification/Accreditation
10. Payment/Insurance/Funding Accepted
11. Payment Assistance Available
12. Assessment/Pre-treatment
13. Screening & Testing
14. Transitional Services
15. Ancillary Services
16. Detoxification
17. Counseling Services and Education
18. Medical Services
19. Tobacco/Screening Services
20. Facility Smoking Policy
21. Age Groups Accepted
22. Gender Accepted
23. Exclusive Services

Here are the full facility listing details on Aliviane Inc Methadone Treatment Program in El Paso, TX:

Phone #: 915-779-4527

Is Methadone a safe option for addiction treatment?

Methadone treatment can be a safe and effective option for individuals struggling with opioid addiction, especially when administered under the supervision of a qualified healthcare provider as part of a comprehensive addiction treatment program, such as the one that can be found at Aliviane Inc Methadone Treatment Program. Methadone is an opioid medication that is used to help manage opioid withdrawal symptoms and cravings, making it easier for individuals to reduce or quit their use of other opioids like heroin or prescription painkillers.

Here are some key points to consider regarding the safety of methadone treatment:

1. Supervised Administration: Methadone treatment is typically provided through opioid treatment programs (OTPs) or clinics where patients receive a daily dose of methadone under the supervision of healthcare professionals. This helps reduce the risk of misuse and overdose.

2. Reduces Withdrawal Symptoms: Methadone can alleviate the severe withdrawal symptoms associated with opioids, which can be a significant barrier to recovery. This can enhance the patient's quality of life and make it easier for them to engage in therapy and counseling.

3. Harm Reduction: Methadone maintenance treatment can be viewed as a harm reduction approach. While it doesn't necessarily lead to immediate abstinence, it reduces the risks associated with illicit opioid use, such as overdose and the transmission of infectious diseases (e.g., HIV and hepatitis).

4. Individualized Treatment: Methadone treatment should be individualized to meet the unique needs of each patient. The dose is typically adjusted based on the patient's response and progress in treatment.

5. Legal Regulation: Methadone clinics and providers are subject to strict regulations and oversight by government agencies to ensure safety and appropriate use of the medication.

However, it's important to note that methadone is an opioid itself and can be habit-forming. When taken as prescribed and under medical supervision, the risk of addiction to methadone is relatively low. However, misuse or diversion of methadone can lead to addiction and other negative consequences.

Methadone treatment is not suitable for everyone. Individuals with certain medical conditions or contraindications may not be candidates for methadone treatment. It's essential for addiction treatment centers like Aliviane Inc Methadone Treatment Program to conduct a thorough assessment before starting someone on methadone.